Table 4.
Baseline Predictor | Odds Ratio | Coefficient (95% CI) |
P value | P value for overall test |
---|---|---|---|---|
Report of depressive symptoms (versus non-report) | 0.37 | [0.17; 0.78] | 0.01 | |
Male (vs female) | 1.98 | [0.91; 4.30] | 0.08 | |
Age (10 years more) | 1.39 | [1.00; 1.93] | 0.05 | |
Main primary diagnosis | 0.04§ | |||
Non cholestatic cirrhosis | 1.98 | [0.67; 5.89] | 0.22 | |
Hepatocellular carcinoma | 0.46 | [0.14; 1.45] | 0.19 | |
Metabolic disorders | 1.73 | [0.58; 5.19] | 0.33 | |
Others liver diseases | 2.67 | [1.24; 5.72] | 0.01 | |
Glomerulopathies | 1.21 | [0.58; 2.54] | 0.61 | |
Tubulo-interstitial nephropathies | 1.37 | [0.41; 4.61] | 0.61 | |
Vascular nephropathies | 0.33 | [0.08; 1.28] | 0.11 | |
Others nephropathies | 0.44 | [0.14; 1.38] | 0.16 | |
Length since the main primary diagnosis | * | * | 0.005§ | |
<1 year | 1.41 | [0.61; 3.28] | 0.43 | |
1 to 5 years | 0.34 | [0.17; 0.70] | 0.003 | |
5 to 10 years | 1.12 | [0.57; 2.22] | 0.74 | |
>10 years | 1.86 | [1.03; 3.37] | 0.04 |
OR, Odds Ratio for 18-month graft failure
CI, Confidence Interval